RCMI Coordinating Center (RCMI CC) Header Logo

Connection

María J. Crespo to Cardiomyopathy, Dilated

This is a "connection" page, showing publications María J. Crespo has written about Cardiomyopathy, Dilated.
Connection Strength

1.458
  1. Crespo MJ, Cangiano JL, Altieri PI, Escobales N. Aliskiren improves left ventricular dysfunction and reduces cardiac dilation in Syrian cardiomyopathic hamsters. J Cardiovasc Pharmacol. 2012 Jun; 59(6):547-52.
    View in: PubMed
    Score: 0.428
  2. Crespo MJ, Cruz N, Altieri PI, Escobales N. Chronic treatment with N-acetylcysteine improves cardiac function but does not prevent progression of cardiomyopathy in Syrian cardiomyopathic hamsters. J Cardiovasc Pharmacol Ther. 2011 Jun; 16(2):197-204.
    View in: PubMed
    Score: 0.386
  3. Crespo MJ, Cruz N, Altieri PI, Escobales N. Enalapril and losartan are more effective than carvedilol in preventing dilated cardiomyopathy in the Syrian cardiomyopathic hamster. J Cardiovasc Pharmacol Ther. 2008 Sep; 13(3):199-206.
    View in: PubMed
    Score: 0.326
  4. Crespo MJ, Zalaca?n J, Dunbar DC, Cruz N, Arocho L. Cardiac oxidative stress is elevated at the onset of dilated cardiomyopathy in streptozotocin-diabetic rats. J Cardiovasc Pharmacol Ther. 2008 Mar; 13(1):64-71.
    View in: PubMed
    Score: 0.319
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support